Long-Term Keto May Cause Metabolic Harm: What 2026 Research Shows
A study published in Science Advances in January 2026 raises important concerns about the long-term safety of the ketogenic diet. While the diet prevented weight gain in the animal model studied, mice on a prolonged ketogenic diet (over nine months) developed fatty liver disease, abnormal blood lipids, and a worsening ability to control blood sugar, particularly after carbohydrates were reintroduced. Initial liver changes appeared within just a few days; impaired glucose tolerance emerged after two to three months. Notably, the damage was sex-dependent: male mice experienced severe metabolic dysfunction while female mice remained largely protected. The findings contrast with the broadly positive short-term results seen in human trials of 8 to 24 weeks and call for longer-duration human studies before continuous multi-year keto can be confidently recommended.
The Science Advances study: what happened over time
Researchers placed mice on a ketogenic diet for over nine months and tracked metabolic outcomes. Despite preventing the weight gain seen in control mice, the keto group developed hepatic steatosis (fatty liver) — with initial changes appearing within just a few days — dyslipidemia (abnormal blood fats), and progressively impaired glucose tolerance that emerged after two to three months. Crucially, when carbohydrates were reintroduced, the animals' blood sugar control was significantly worse than at baseline — a pattern consistent with acquired insulin secretory dysfunction. The authors attributed the impaired insulin secretion to cellular stress in beta cells caused by chronic fat exposure. Notably, the damage was sex-dependent: male mice developed severe fatty liver and metabolic dysfunction while female mice remained largely protected — a difference flagged for further investigation. After stopping the ketogenic diet, blood sugar regulation improved. (Study: Science Advances 2026; summary: ScienceDaily)
Why short-term and long-term keto outcomes differ
Most human clinical trials of the ketogenic diet run for 8–24 weeks, a period during which the diet's benefits — weight loss, improved insulin sensitivity, lower triglycerides — are well documented. The 2026 animal study highlights a potential divergence: metabolic adaptations that appear beneficial in the short term may become maladaptive over a prolonged timeframe. Specifically, the chronic suppression of pancreatic beta cells during extended ketosis may reduce their capacity to respond to glucose, which could undermine glycemic control if and when carbohydrates are reintroduced.
The fatty liver paradox: keto short-term versus long-term
The 2026 finding that long-term keto caused fatty liver stands in apparent contradiction to the same year's MASLD trial data showing keto dramatically reduces liver fat in the short term. Researchers suggest the explanation lies in the duration of exposure and metabolic context: a 12-week very low-energy keto intervention reduces pre-existing liver fat in insulin-resistant humans, while a sustained state of dietary ketosis over many months in already-lean mice — where the liver is not drawing on stored fat as a therapeutic target — may lead to lipid accumulation from a different mechanism.
How relevant are animal findings for humans?
Animal studies, especially in mice, do not always translate directly to humans. Mice metabolize carbohydrates and fats differently and have much shorter lifespans, meaning that 'long-term' in a mouse model compresses what would be years in human time. That said, the mechanisms identified — beta cell suppression, lipid dysregulation — are biologically plausible in humans too. Epidemiological data from long-term low-carbohydrate dieters in human populations is still emerging, and no large-scale, multi-year randomized controlled trial in humans has been completed as of 2026.
What this means if you follow keto
The 2026 data does not suggest that the ketogenic diet is dangerous in the short to medium term for most healthy adults. However, it underscores the importance of regular medical monitoring for anyone following a ketogenic diet for more than six months. Key parameters to track include fasting glucose, HbA1c, liver enzymes (ALT, AST), fasting insulin, and the full lipid panel. Anyone planning to transition off a long-term ketogenic diet should do so gradually rather than abruptly reintroducing large amounts of carbohydrates, and ideally with guidance from a physician or registered dietitian.
FAQ
Does long-term keto cause liver damage?
The 2026 mouse study found that prolonged ketogenic dieting caused fatty liver in animals, even without weight gain — with changes appearing within just a few days. Importantly, the damage was sex-dependent: male mice experienced severe fatty liver, while female mice remained largely protected. This contrasts with short-term human trials showing keto reduces liver fat. The long-term picture in humans is not yet well established. Regular liver enzyme monitoring (ALT, AST) is advisable for anyone following keto for more than 6 months.
Can you develop insulin resistance from long-term keto?
The Science Advances 2026 study found that prolonged keto impaired insulin secretion in mice, particularly after carbohydrate reintroduction. Whether this occurs in humans over years of ketogenic dieting is not confirmed by existing evidence, but the mechanistic concern is real. If you follow keto long-term, regular HbA1c and fasting glucose testing is recommended.
How long is it safe to stay on a ketogenic diet?
There is no universally agreed 'safe duration' for the ketogenic diet. Most clinical evidence is from trials of 8–24 weeks. For longer-term use, individual monitoring is essential. Discuss any long-term dietary plan with a physician who can track relevant metabolic biomarkers over time.